Amazon Pharmacy medical chief Gupta is latest health exec to leave company

Amazon Pharmacy medical chief Gupta is latest health exec to leave company


Vin Gupta, Chief Medical Officer at Amazon Pharmacy, speaks during Amazon’s “Delivering the Future” event at the company’s BFI1 Fulfillment Center, Robotics Research and Development Hub in Sumner, Washington on October 18, 2023. 

Jason Redmond | Afp | Getty Images

Amazon has lost the chief medical officer of its pharmacy division after five years at the company.

Dr. Vin Gupta, who most recently served as the medical chief of Amazon Pharmacy, joined Amazon in 2020 as the company was in the early stages of a multi-year effort to build out a health-care business.

Gupta has joined Manatt, Phelps & Phillips, LLP, a professional services firm, as a managing director to lead a portfolio dedicated to health innovation, according to a release. Amazon didn’t immediately name a successor for Gupta, whose LinkedIn profile says he left last month.

“We are grateful to Dr. Gupta for all of his contributions to Amazon Health Services and wish him the best in his next endeavor,” an Amazon spokesperson told CNBC in a statement Wednesday.

Gupta said in an emailed statement that Manatt, like Amazon, “is deeply focused on scaled impact to address problems which matter to patients nationwide,” including care access and the use of artificial intelligence “at the point of need.”

For Amazon CEO Andy Jassy, Gupta’s exit marks another high-profile departure across the health businesses. Earlier this month, One Medical CEO Trent Green announced he would step down from leading the primary care chain in April, after less than two years in the role. Amazon acquired One Medical for $3.9 billion in 2023, five years after snapping up online pharmacy PillPack for about $750 million.

In addition to his role within the pharmacy business, Gupta held several other positions over the course of his five years at the company, including Covid response lead and chief medical officer of new products in Amazon’s devices and services unit.

Gupta joined Amazon months before it launched its pharmacy offering, a service that was born out PillPack deal in 2018. In his role as chief medical officer, Gupta helped roll out a prescription perk for U.S. Prime members called RxPass and expanded its program for medication delivery by drones.

Gupta was also involved with a moonshot incubator at Amazon called Grand Challenge, which launched under founder Jeff Bezos as a way to develop experimental businesses, including health-care initiatives.

Disclosure: Dr. Vin Gupta contributes to NBC News as a medical analyst.

WATCH: Amazon Pharmacy chief medical officer on expanded ‘RxPass’ access

Amazon's Vin Gupta on expanded 'RxPass' access



Source

Week in review: The Nasdaq’s worst week since April, three trades, and earnings
Technology

Week in review: The Nasdaq’s worst week since April, three trades, and earnings

It was a terrible start to November on Wall Street. The tech-heavy Nasdaq sank just over 3% in its worst weekly performance since early April. The S & P 500 fell 1.6% for the week. Both stock measures broke three-week winning streaks.This week’s market decline, which followed a strong October, can be chalked up to […]

Read More
People with ADHD, autism, dyslexia say AI agents are helping them succeed at work
Technology

People with ADHD, autism, dyslexia say AI agents are helping them succeed at work

Neurodiverse professionals may see unique benefits from artificial intelligence tools and agents, research suggests. With AI agent creation booming in 2025, people with conditions like ADHD, autism, dyslexia and more report a more level playing field in the workplace thanks to generative AI. A recent study from the UK’s Department for Business and Trade found […]

Read More
Palantir CEO Karp twice slams short sellers as stock suffers worst week since April
Technology

Palantir CEO Karp twice slams short sellers as stock suffers worst week since April

Palantir co-founder and CEO Alex Karp attends meetings at the U.S. Capitol in Washington on Oct. 18, 2023. Jonathan Ernst | Reuters With Palantir’s stock plummeting more than 11% this week despite a better-than-expected earnings report, CEO Alex Karp took aim at investors betting against the software company. Karp, who co-founded Palantir in 2003, went […]

Read More